Clinical Trials Logo

Determination of Death clinical trials

View clinical trials related to Determination of Death.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05038943 Completed - Clinical trials for Extracorporeal Membrane Oxygenation

Evaluation of Safety and Effectiveness of The SherpaPak in Donation After Circulatory Death Heart Transplantation

Start date: September 15, 2021
Phase: N/A
Study type: Interventional

This is a prospective, pilot trial to evaluate the safety and effectiveness of The Paragonix SherpaPak™ Cardiac Transport System ("SherpaPak CTS") in transportation of cardiac allografts recovered from donors after circulatory death with thoracoabdominal normothermic regional perfusion (TA-NRP). SherpaPak™ CTS is an ultraportable hypothermic preservation and transport system that has been approved by United States Food & Drug Administration (FDA) for clinical use in heart transplantation.

NCT ID: NCT04626284 Completed - Death Clinical Trials

Safety and Effectiveness of NRP for DCD Heart Transplantation

DCDNRPHeart
Start date: January 3, 2021
Phase: N/A
Study type: Interventional

This is a prospective, observational, pilot trial to evaluate the feasibility of heart transplantation using normothermic regional perfusion (NRP) donation after donor circulatory death (DCD). Normothermic regional perfusion utilizes Extracorporeal Membrane Oxygenation (ECMO) or cardiopulmonary bypass to reperfuse the heart and other organs in situ after isolation and ligation of the cerebral vessels. In situ resuscitation of the heart has the added advantage of allowing full hemodynamic and echocardiographic assessment of the donor heart prior to final acceptance for transplantation without the imminent danger of ongoing warm ischemia.